Anke Niedernberg
Corporate Officer/Principal at ADVANZ PHARMA CORP. LIMITED
Profile
Anke Niedernberg is currently the Chief Transformation Officer at Advanz Pharma Corp.
Ltd.
She was previously a Partner at HgCapital Beratungs GmbH & Co. KG from 2008 to 2010.
Anke Niedernberg active positions
| Companies | Position | Start |
|---|---|---|
| ADVANZ PHARMA CORP. LIMITED | Corporate Officer/Principal | 2021-09-30 |
Former positions of Anke Niedernberg
| Companies | Position | End |
|---|---|---|
| HgCapital Beratungs GmbH & Co. KG | Private Equity Investor | 2009-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| HgCapital Beratungs GmbH & Co. KG | Finance |
Advanz Pharma Corp. Ltd.
 Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Anke Niedernberg
